Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/28/2025
12/29/2024
12/31/2023
01/01/2023
01/02/2022
Revenue
94,193
94,193
88,821
85,159
79,990
78,740
Revenue Growth (YoY)
6%
6%
4%
6%
2%
-5%
Cost of Revenue
30,221
30,256
27,436
26,244
24,596
23,402
Gross Profit
63,972
63,937
61,385
58,915
55,394
55,338
Selling, General & Admin
23,676
23,676
22,869
21,512
20,246
20,118
Research & Development
14,665
14,665
17,232
15,085
14,135
14,277
Operating Expenses
37,809
31,132
37,881
34,665
32,105
34,705
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
32,581
32,581
16,687
15,062
19,359
19,178
Income Tax Expense
5,777
5,777
2,621
1,736
2,989
1,377
Net Income
26,804
26,804
14,066
35,153
17,941
20,878
Net Income Growth
91%
91%
-60%
96%
-14%
42%
Shares Outstanding (Diluted)
2,439
2,429.4
2,429.4
2,560.4
2,663.9
2,674
Shares Change (YoY)
0%
0%
-5%
-4%
0%
0%
EPS (Diluted)
10.98
11.03
5.79
13.72
6.73
7.8
EPS Growth
90%
91%
-57.99%
104%
-14%
42%
Free Cash Flow
19,698
19,698
19,842
18,248
17,185
19,758
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
67.91%
67.87%
69.11%
69.18%
69.25%
70.27%
Operating Margin
27.77%
34.82%
26.46%
28.47%
29.11%
26.2%
Profit Margin
28.45%
28.45%
15.83%
41.27%
22.42%
26.51%
Free Cash Flow Margin
20.91%
20.91%
22.33%
21.42%
21.48%
25.09%
EBITDA
33,666
40,308
30,843
31,736
30,259
28,023
EBITDA Margin
35.74%
42.79%
34.72%
37.26%
37.82%
35.58%
D&A For EBITDA
7,503
7,503
7,339
7,486
6,970
7,390
EBIT
26,163
32,805
23,504
24,250
23,289
20,633
EBIT Margin
27.77%
34.82%
26.46%
28.47%
29.11%
26.2%
Effective Tax Rate
17.73%
17.73%
15.7%
11.52%
15.43%
7.18%
Follow-Up Questions
What are Johnson & Johnson's key financial statements?
According to the latest financial statement (Form-10K), Johnson & Johnson has a total asset of $199,210, Net profit of $26,804
What are the key financial ratios for JNJ?
Johnson & Johnson's Current ratio is 1.69, has a Net margin is 28.45, sales per share of $38.77.
How is Johnson & Johnson's revenue broken down by segment or geography?
Johnson & Johnson largest revenue segment is Consumer Health, at a revenue of 14,953,000,000 in the most earnings release.For geography, United States is the primary market for Johnson & Johnson, at a revenue of 53,752,000,000.
Is Johnson & Johnson profitable?
yes, according to the latest financial statements, Johnson & Johnson has a net profit of $26,804
Does Johnson & Johnson have any liabilities?
yes, Johnson & Johnson has liability of 117,666
How many outstanding shares for Johnson & Johnson?
Johnson & Johnson has a total outstanding shares of 2,407.93